MK-8998

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8998, covering 2014-02-06 to 2014-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004) [Phase 2]

See pricing